Newsroom

MILANO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. ha annunciato oggi che il Comitato per i medicinali per uso umano (CHMP) dell’Agenzia europea per i medicinali (EMA) ha espresso un parere positivo riguardo alla concessione dell’autorizzazione all’immissione in commercio di trofinetide per il trattamento dei sintomi neurocomportamentali della sindrome di Rett in pazienti adulti e pediatrici di età pari o superiore a 5 anni. Se approvato dalla Commissione europea, trofinetide sarebbe il primo...

TURÍN, Italia--(BUSINESS WIRE)--Roboverse Reply, la empresa de Reply Group especializada en robótica y automatización, obtuvo el primer puesto en la categoría «Reconocimiento» y un premio especial al «Mejor trabajo en equipo» en el European Land Robot Trial (ELROB) 2026 celebrado en Thun, Suiza. En colaboración con ELP, empresa especializada en equipos técnicos para servicios de desactivación de explosivos, la empresa demostró un rendimiento excepcional junto a un grupo de participantes interna...

HOUSTON--(BUSINESS WIRE)--EverLine appoints ERCOT CEO Pablo Vegas to its Board, strengthening leadership in critical infrastructure, grid operations, and cybersecurity....

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) gab heute bekannt, dass der Ausschuss für Humanarzneimittel (CHMP) der Europäischen Arzneimittelagentur (EMA) nach Abschluss eines Wiederprüfungsverfahrens eine positive Stellungnahme abgegeben hat, in der eine Marktzulassung von DAYBU® (Trofinetide) zur Behandlung neurobehavioraler Symptome des Rett-Syndroms bei Erwachsenen sowie bei pädiatrischen Patientinnen und Patienten ab einem Alter von fünf Jahren empfohlen wird. Im...

SAN FRANCISCO--(BUSINESS WIRE)--Andersen Consulting forstærker sine kompetencer inden for teknologisk transformation gennem en samarbejdsaftale med House of Code, en global virksomhed med hovedkvarter i USA, der specialiserer sig i datadrevne platforme, automatisering og agentbaserede ai-løsninger. House of Code blev stiftet i 2001 og udvikler softwareløsninger samt yder rådgivning til energihandels- og finanssektoren med kunder, der spænder over hedgefonde, kapitalfonde og forsyningsvirksomhed...

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq : ACAD) a annoncé ce jour que le Comité des médicaments à usage humain (CHMP) de l’Agence européenne des médicaments (EMA) a rendu un avis favorable recommandant l’octroi d’une autorisation de mise sur le marché du DAYBU® (trofinetide) dans le traitement des symptômes neuro-comportementaux du syndrome de Rett chez l’adulte et en pédiatrie chez des patients âgés de 5 ans et plus. Si cette autorisation est accordée par la Commission...

NEW YORK--(BUSINESS WIRE)--Researchers at Hospital for Special Surgery (HSS) have uncovered a critical link between the immune system in early life and its function in adulthood. The study, published in Science Immunology, identifies a new role for specialized skin immune cells, called Langerhans cells, in shaping the development of lymphatic vessels—an essential part of the body’s immune network. Lymphatic vessels act as communication highways, carrying signals from tissues to the immune syste...

LONDON--(BUSINESS WIRE)--Global management and technology consultancy Capco, a Wipro company, has been recognized by OpenAI for both AI innovation and responsible AI leadership. Capco received the AI Governance & Risk Excellence Award at the recent OpenAI Partner Summit 2026 in San Francisco, highlighting Capco’s ability to deliver enterprise-grade AI outcomes in highly regulated environments. The award recognizes Capco’s expert advantage when helping financial services and energy organizat...

BEAVERTON, Ore.--(BUSINESS WIRE)--Gurobi Optimization, LLC, leader nel settore della tecnologia di intelligence decisionale, ha annunciato oggi il lancio di Gurobean: The Coffee Optimization Game, un nuovo gioco educativo che porta alla luce concetti come la non-linearità, la simulazione e il processo decisionale in condizioni di incertezza. Sulla scia del successo riscontrato dal Burrito Optimization Game, che dal suo lancio nel 2022 è stato giocato oltre 85.000 volte da studenti in tutto il m...

SAN DIEGO--(BUSINESS WIRE)--Vandaag heeft Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) bekendgemaakt dat het Comité voor geneesmiddelen voor menselijk gebruik (Committee for Medicinal Products for Human Use, CHMP) van het Europees Geneesmiddelenagentschap (EMA) een positief advies heeft uitgebracht waarin de verlening van een handelsvergunning wordt aanbevolen voor DAYBU® (trofinetide) voor de behandeling van neuro gedragsgerelateerde symptomen van het Rett-syndroom bij volwassenen en kinderen va...